During the past decade, Nemocnice Ceske Budejovice,a.s. conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 13 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Ceske Budejovice,a.s." #1 sponsor was "Bayer" with 5 trials, followed by "Biotronik SE & Co. KG" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Biosense Webster, Inc." with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Ceske Budejovice,a.s." #1 collaborator was "České Budějovice Hospital" with 2 trials as a collaborator, "ASOKLIF" with 1 trials as a collaborator, "Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse" with 1 trials as a collaborator, "BUPA Foundation" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Ceske Budejovice,a.s." are "Atrial Fibrillation" (3 trials), "Psoriasis" (3 trials), "Aneurysmal Subarachnoid Hemorrhage" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Nemocnice Ceske Budejovice,a.s." in a lesser frequency.

Most popular intervention types in "Nemocnice Ceske Budejovice,a.s." are "Drug" (25 trials), "Device" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Guselkumab" (3 trials), "Apixaban" (2 trials), "BAY2433334" (2 trials) and "BAY2433334 matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Ceske Budejovice,a.s." are 39 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Nemocnice Ceske Budejovice,a.s.". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Nemocnice Ceske Budejovice,a.s., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Ceske Budejovice,a.s., 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".